Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00099411 · ClinicalTrials.gov registry record
Heart Muscle Viability and Remodeling in Individuals Post-Heart Attack
A clinical trial, sponsored by Tufts Medical Center.
- Completed
- Registry status
- 124
- Enrollment target
NCT00099411: Completed study, sponsored by Tufts Medical Center.
NCT00099411 is a clinical trial that has completed, run by Tufts Medical Center. The registered enrollment target is 124 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00099411 has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- 124 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effect of heart muscle viability on left ventricular (LV) remodeling after a heart attack; to explore the relationships between retained viability of the area of tissue death (infarct zone), LV remodeling, response to the Occluded Artery Trial (OAT) intervention, and response to late percutaneous coronary intervention of the infarct related artery (IRA).
Primary Outcome
The primary end point of LV remodeling was assessed by change in LV EDV from baseline to 1 year.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2004-01 |
| Est. Completion | 2007-06-30 |
What the finished NCT00099411 record still lists
NCT00099411 is an observational study that tracks outcomes without assigning an intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00099411 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00099411 about?
NCT00099411 is a clinical study titled "Heart Muscle Viability and Remodeling in Individuals Post-Heart Attack". The purpose of this study is to assess the effect of heart muscle viability on left ventricular (LV) remodeling after a heart attack; to explore the relationships between retained viability of the area of tissue death (infarct zone), LV remodeling, response to the Occluded Artery Trial (OAT) interve...
What is the current status of trial NCT00099411?
This trial is currently completed. The enrollment target is 124 participants. The study started on 2004-01. Estimated completion is 2007-06-30.
Who is sponsoring clinical trial NCT00099411?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523014 · 124 participants · Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- NCT02670707 · 124 participants · Phase 3
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- NCT02830724 · 124 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- NCT04748809 · 124 participants · NA
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia